Interdisciplinary collaboration
Access to the resources of Stanford University -- including the Schools of Engineering, Law, Business, Humanities & Sciences and Education
Excellence in Scientific Discovery
The Institute's comprehensive investigations extend from the earliest phase of basic discovery to the development of new cancer diagnostics, treatment protocols and prevention strategies
Research Programs
Basic, clinical and translational studies into the biology of cancer and the factors that contribute to its onset and growth.
Shared Resources
The most sophisticated technologies and research protocols are offered to SCI members through a number of core facilities.
Seminars
Ongoing seminars allow cancer specialists to share knowledge and foster new collaborations.
Training Opportunities
Education and professional development designed to train the next generation of cancer researchers and physicians.
Clinical Trial Support
The Cancer Clinical Trials Office provides regulatory and administrative services to SCI members conducting clinical trials.
Funding Opportunities
Internal and external sources of support for both established cancer research programs and promising new ideas.
News & Publications
Publications, press releases and news are shared with scientists, physicians, patients and friends of the Institute.
Institute Membership
Scientists and physicians from a wide range of disciplines, all dedicated to reducing the burden of cancer.
National Cancer Institute Designation
In addition to providing grants and other support to cancer researchers at institutions around the country, the National Cancer Institute employs scientists who conduct basic, clinical, and population-based research, including the study of rare cancers and the translation of laboratory findings to the clinic.
News & Publications
-
Common treatment for prostate cancer appears to double Alzheimer’s risk
Short-circuiting the need for expensive clinical trials, researchers uncovered an association between androgen blockers and cognitive decline by examining patient medical records.
-
New class of RNA tumor suppressors identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
-
Researchers receive outstanding investigator awards from National Cancer Institute
Steven Artandi, Laura Attardi and Amato Giaccia will receive up to $600,000 annually for seven years to study cancer processes.
